The constant mental chatter about foodwhat many people describe as food noisesuddenly went quiet
Diabetes Epidemiology and Management, 12, 100162
This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications
These are separate trials with different populations, durations, and designs, not a head-to-head study, so direct ranking requires caution
The t ,semaglutide,SS was comparable between treatment groups, with geometric means of 153, 161 and 158 h in healthy subjects receiving 20 and 40 mg and subjects with T2D receiving 40 mg, respectively, i.e
doi: 10.1016/j.neuropharm.2013.08.005 159 HolubovaMHrubaLPopelovaABenczeMPrazienkovaVGenglerSet al